GROSSI, Ilaria
 Distribuzione geografica
Continente #
NA - Nord America 2.608
EU - Europa 1.804
AS - Asia 1.656
SA - Sud America 303
AF - Africa 40
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.417
Nazione #
US - Stati Uniti d'America 2.548
SG - Singapore 595
PL - Polonia 463
IT - Italia 429
CN - Cina 422
DE - Germania 256
BR - Brasile 250
HK - Hong Kong 148
VN - Vietnam 143
FI - Finlandia 125
FR - Francia 103
UA - Ucraina 102
GB - Regno Unito 82
BD - Bangladesh 76
IN - India 74
RU - Federazione Russa 69
TR - Turchia 50
ID - Indonesia 38
SE - Svezia 36
CA - Canada 32
IE - Irlanda 30
BE - Belgio 27
NL - Olanda 25
AR - Argentina 21
MX - Messico 16
JP - Giappone 15
AT - Austria 14
IQ - Iraq 12
RO - Romania 12
ZA - Sudafrica 12
KR - Corea 10
AE - Emirati Arabi Uniti 8
ES - Italia 8
PK - Pakistan 8
EC - Ecuador 7
SA - Arabia Saudita 7
JO - Giordania 6
KE - Kenya 6
MA - Marocco 6
OM - Oman 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
CO - Colombia 5
LT - Lituania 5
LY - Libia 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
IR - Iran 4
PY - Paraguay 4
TH - Thailandia 4
AZ - Azerbaigian 3
EG - Egitto 3
JM - Giamaica 3
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
TM - Turkmenistan 2
TN - Tunisia 2
AL - Albania 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RE - Reunion 1
SD - Sudan 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.417
Città #
Warsaw 462
Singapore 314
Ashburn 239
San Jose 199
Chandler 159
Hong Kong 142
Brescia 141
Fairfield 110
New York 106
The Dalles 104
Beijing 103
Los Angeles 94
Council Bluffs 90
Ann Arbor 86
Jacksonville 82
Helsinki 77
Houston 69
Chicago 63
Munich 60
Dallas 58
Woodbridge 56
Wilmington 52
Ho Chi Minh City 50
Buffalo 49
Cambridge 48
Lauterbourg 48
Princeton 42
Seattle 42
Istanbul 41
Milan 39
Des Moines 32
Dublin 30
Jakarta 30
Nanjing 28
Santa Clara 28
Brussels 27
São Paulo 27
Dong Ket 26
Shanghai 25
San Francisco 24
Lappeenranta 23
Orem 23
Salt Lake City 23
Moscow 22
Turku 19
Redondo Beach 18
Atlanta 17
Nuremberg 17
Brooklyn 16
Hanoi 15
Phoenix 14
Pune 14
Tampa 14
Frankfurt am Main 13
Mexico City 13
Tokyo 13
Amsterdam 12
Bari 11
Chennai 11
Mumbai 10
Rio de Janeiro 10
Rome 10
Romola 10
Changsha 9
Dearborn 9
London 9
Manchester 9
Montreal 9
Denver 8
Elk Grove Village 8
Jiaxing 8
Sundbyberg 8
Toronto 8
Botucatu 7
Dulles 7
Guangzhou 7
Johannesburg 7
Magnago 7
Ottawa 7
Poplar 7
Sterling 7
Vienna 7
Amman 6
Ankara 6
Boston 6
Jinan 6
Lancaster 6
Riyadh 6
San Diego 6
Stockholm 6
Tianjin 6
Boardman 5
Brasília 5
Da Nang 5
Haiphong 5
Nairobi 5
North York 5
Nürnberg 5
Porto Alegre 5
Shenyang 5
Totale 4.097
Nome #
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 338
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 259
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 230
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 223
Functional Role of microRNA-23b-3p in Cancer Biology 221
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 219
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 215
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 207
Biological Function of MicroRNA193a-3p in Health and Disease 206
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 183
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 181
microRNAs and human hepatocellular carcinoma 179
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 173
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 167
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 164
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 149
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 149
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 146
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma 139
DNA methylation variations in familial female and male breast cancer 133
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 129
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 124
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 116
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 111
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 106
Lasp1 expression is implicated in embryonic development of zebrafish 100
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib 96
Determination of longitudinal Circulating levels of miR-21-5p, miR-23b-3p and miR-34a-5p in plasma of patients with glioblastoma using droplet digital PCR 95
The enrichment of miR-23b-3p, miR-126-3p and GAS5 in extracellular vesicles from breast cancer cells treated with sorafenib inhibited the tumor growth of xenografts in zebrafish model 94
Cabozantinib in neuroendocrine tumours: tackling drug activity and resistance mechanisms 92
miR-23b-3p, miR-126-3p and GAS5 encapsulated in extracellular vesicles from breast cancer cells treated with sorafenib inhibited the growth of tumor xenografts in zebrafish model 92
miR-23b-3p, miR-126-3p and GAS5 delivered by extracellular vesicles inhibit breast cancer xenografts in zebrafish 91
Emerging role of TElomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 91
The delivery of miR-23b-3p, miR-126-3p, and GAS5 by extracellular vesicles inhibited the tumor growth of zebrafish breast cancer xenografts. 89
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 88
EFFECTS OF miR-23b-3p, miR-126-3p, AND GAS5 DELIVERED BY EVs ON BREAST CANCER XENOGRAFTS DEVELOPED IN ZEBRAFISH. 86
Extracellular vesicles derived from breast cancer cells rich in miR-23b-3p, miR-126-3p, and GAS5 inhibited the tumor growth of zebrafish xenograft model. 84
Droplet digital PCR Development to quantify the DNA methylation levels of SEPT9 and SHOX2 in plasma from patients with Head and Neck Squamous Cell Carcinoma 79
MiR-193a-3p and miR-23b-3p in human hepatocellular carcinoma: from biological function to potential biomedical application 77
Molecular profiling of tissue- and circulating cancer related non coding RNAs in hepatocellular carcinoma 77
Expression profiling of selected cancer associated-ncRNAs in tissue and liquid biopsies from patients with human hepatocellular carcinoma 76
The Biological Role and Translational Implications of the Long Non-Coding RNA GAS5 in Breast Cancer 74
Extracellular vesicles derived from breast cancer cells rich in miR-23b-3p, miR-126-3p, and GAS5 inhibited the tumor growth of zebrafish xenograft model 70
Profiling of miR-98-5p, miR-130a-3p, and miR-1246 levels in tissue and liquid biopsies of patients with hepatocellular carcinoma. 66
Molecular profiling of tissue and circulating cancer-related ncRNA in hepatocellular carcinoma 62
The cellular and extracellular forms of the non-coding RNAs TERRA and TERC and TERT mRNA are dysregulated in human hepatocellular carcinoma. 60
The cellular and extracellular forms of the non-coding RNAs TERRA and TERC and TERT mRNA are dysregulated in human hepatocellular carcinoma. 56
Regulation of microRNA-23b-3p and microRNA-193a-3p expression by DNA methylation in human hepatocellular carcinoma 50
The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation 45
Modulation of tumor-suppressor ncRNAs in cancer cells via administration of extracellular vesicles released by sorafenib-treated cells. 41
MiR-98-5p, miR-130a-3p, and miR-1246 levels in tissue and liquid biopsies of patients with hepatocellular carcinoma 38
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 34
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 32
Totale 6.502
Categoria #
all - tutte 26.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022218 22 25 21 14 2 13 6 15 18 20 18 44
2022/2023365 35 32 17 43 39 72 11 33 45 4 11 23
2023/2024470 38 12 68 34 17 96 17 21 54 30 18 65
2024/20251.352 25 33 40 171 76 80 99 47 165 77 383 156
2025/20262.530 188 231 181 335 253 249 360 105 163 261 119 85
2026/202727 27 0 0 0 0 0 0 0 0 0 0 0
Totale 6.502